Europäische Marktprognose für PCR-Technologien bis 2030 – Regionale Analyse – nach Technologie (Echtzeit-PCR, konventionelle PCR, Reverse-Transkriptase-PCR, digitale PCR, Multiplex-RT-PCR, Hot-Start-PCR und andere), Angebot (Reagenzien und Verbrauchsmaterialien, Instrumente sowie Software und Dienstleistungen), Anwendung (Genexpressionsanalyse, genetische Sequenzierung, Genotypisierung, Nukleinsäuresynthese, Standardvalidierung, Point-of-Care-Diagnostik, Umweltanwendung und andere) und Endbenutzer (Krankenhäuser und Diagnosezentren, Hochschulen und Forschungsinstitute, Pharma- und Biotechnologieunternehmen und andere)
Zunehmende Einführung von PCR-Techniken in Schwellenländern treibt europäischen Markt für PCR-Technologien an
Point-of-Care-Tests (POC) bieten dem Markt für PCR-Technologien eine große Chance, da sie ihre Reichweite und Anwendungsmöglichkeiten erweitern. Die PCR-Technologie, die für ihre Genauigkeit und Empfindlichkeit bekannt ist, wird zunehmend für POC-Tests eingesetzt, da sie schnelle und zuverlässige Ergebnisse am oder nahe dem Point of Care liefert. Da POC-Tests in Gesundheitseinrichtungen wie Kliniken, Notaufnahmen und dezentralen Einrichtungen immer häufiger eingesetzt werden, wird die Nachfrage nach PCR-Plattformen und -Tests, die auf POC-Anwendungen zugeschnitten sind, voraussichtlich steigen.
Die Vorteile der PCR, darunter die Fähigkeit, Infektionskrankheiten mit hoher Spezifität und Sensitivität zu erkennen, machen sie für POC-Tests gut geeignet, insbesondere in Situationen, in denen schnelle Diagnose- und Behandlungsentscheidungen erforderlich sind. Darüber hinaus ermöglichen die Miniaturisierung und Automatisierung von PCR-Systemen ihre Integration in POC-Umgebungen, was Tests vor Ort erleichtert und die Ergebnisse der Patientenversorgung verbessert. Da Gesundheitsdienstleister zunehmend den Wert von POC-PCR-Tests zur Verbesserung der Diagnosemöglichkeiten und des Patientenmanagements erkennen, ist der Markt für POC-PCR-Technologien bereit für Wachstum und Innovation.
Überblick über den europäischen Markt für PCR-Technologien
Der europäische Markt für PCR-Technologien ist in Deutschland, Großbritannien, Frankreich, Italien, Spanien und das übrige Europa unterteilt. Von staatlichen und privaten Organisationen bereitgestellte Mittel für fortgeschrittene Forschung, die Einführung innovativer Technologien für die künstliche DNA-Synthese und eine Zunahme verschiedener Forschungsstudien für neuartige technologiebasierte Anwendungen treiben das Wachstum des Marktes für PCR-Technologien in Europa voran. Darüber hinaus dürften die Bemühungen der nationalen Regierungen, Innovationen durch Anreizbestimmungen und Steuerbefreiungen für Forschung und Entwicklung sowie neue Biotech-Start-ups zu fördern, das Wachstum des europäischen Marktes für PCR-Technologien im Prognosezeitraum begünstigen. Deutschland ist dank der Präsenz prominenter Biotech-Unternehmen, hochtechnologischer Forschungslabore und massiver Finanzierung für Forschungs- und Entwicklungsaktivitäten in den neuen Bereichen von Wissenschaft und Technologie einer der größten Biotechnologie-Standorte in Europa und weltweit. Das Land hat mehr Biotechnologieunternehmen als jedes andere europäische Land. Die in Deutschland betriebene Spitzenforschung und qualitativ hochwertige Forschung schafft lukrative Möglichkeiten für den bereits etablierten Markt für PCR-Technologien. Einzelne Forscher und akademische Universitäten im Land arbeiten mit internationalen Laboren und Institutionen zusammen, um bahnbrechende Innovationen zu schaffen. Die steigenden Mittel und Zuschüsse sowie die zunehmende Nutzung der synthetischen Biologie in verschiedenen Anwendungsbereichen sind die Hauptfaktoren, die das Wachstum des deutschen Marktes für PCR-Technologien begünstigen. Die deutsche Regierung betrachtet die Gründung von Startups als wesentlichen Bestandteil der Entwicklung der Biotechnologiebranche im Land. BIO Deutschland beispielsweise ist ein Branchenverband der deutschen Biotech-Industrie mit Sitz in Berlin und über 330 Mitgliedern, die die Entwicklung der Branche fördern und unterstützen, damit sie zu einem robusten Wirtschaftsunternehmen heranwächst. Auch Euronext ist eine Organisation, die die aktuelle Dynamik der Biotech-Industrie erkennt und nutzt. Sie unterstützt Start-ups, indem sie Arbeitsplätze schafft, Gelder und Investitionen beschafft und die Unternehmen auf verschiedene andere Weise unterstützt.
Umsatz und Prognose des europäischen Marktes für PCR-Technologien bis 2030 (in Millionen US-Dollar)
Segmentierung des europäischen Marktes für PCR-Technologien
Der europäische Markt für PCR-Technologien ist segmentiert in Technologie, Angebote, Anwendung, Endnutzer und Land.
Basierend auf der Technologie ist der europäische Markt für PCR-Technologien in Echtzeit-PCR, konventionelle PCR, Reverse Transkription, digitale PCR, Multiplex-RTPCR, Hot-Start-PCR und andere kategorisiert. Das Segment Echtzeit-PCR hatte 2022 den größten Anteil am europäischen Markt für PCR-Technologien.
In Bezug auf das Angebot ist der europäische Markt für PCR-Technologien in Reagenzien und Verbrauchsmaterialien, Instrumente sowie Software und Dienstleistungen unterteilt. Das Segment Reagenzien und Verbrauchsmaterialien hatte 2022 den größten Anteil am europäischen Markt für PCR-Technologien. Darüber hinaus ist das Segment Reagenzien und Verbrauchsmaterialien in Reagenzien, Fläschchengrößen und andere Verbrauchsmaterialien unterteilt. Darüber hinaus ist die Fläschchengröße in 0,2 ml bis 2 ml, 0,1 ml bis 0,3 ml, 2 ml bis 5 ml und andere Fläschchen unterteilt. Darüber hinaus ist das Instrumentensegment in Tisch-PCR und tragbare Thermocycler/PCR unterteilt.
Nach Anwendung ist der europäische Markt für PCR-Technologien in Genexpressionsanalyse, genetische Sequenzierung, Genotypisierung, Nukleinsäuresynthese, Standardvalidierung, Point-of-Care-Diagnostikanwendung, Umweltanwendung und andere unterteilt. Das Segment Genexpressionsanalyse hielt 2022 den größten Anteil am europäischen Markt für PCR-Technologien.
Basierend auf dem Endbenutzer ist der europäische Markt für PCR-Technologien in Krankenhäuser und Diagnosezentren, Pharma- und Biotechnologieunternehmen, akademische Institute und Forschungslabore und andere unterteilt. Das Segment Krankenhäuser und Diagnosezentren hielt 2022 den größten Anteil am europäischen Markt für PCR-Technologien.
Nach Ländern wurde der europäische Markt für PCR-Technologien in Deutschland, Großbritannien, Frankreich, Italien, Spanien und das übrige Europa unterteilt. Deutschland dominierte 2022 den europäischen Markt für PCR-Technologien.
Thermo Fisher Scientific Inc, Promega Corp, QIAGEN NV, bioMerieux SA, Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Becton Dickinson and Co, Takara Bio Inc, Standard Bio Tools Inc, Agilent Technologies Inc und Ellume Ltd sind einige der führenden Unternehmen auf dem europäischen Markt für PCR-Technologien.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe PCR Technologies Market - Key Industry Dynamics
4.1 PCR Technologies Market - Key Industry Dynamics
4.2 Market Drivers
4.2.1 Rising Prevalence of Genetic and Infectious Diseases
4.2.2 Surging Investments and Funds Availability for PCR Technologies
4.3 Market Restraints
4.3.1 High Costs of PCR Systems and Availability of Alternative Assays
4.4 Market Opportunities
4.4.1 Increasing Demand for POC Testing
4.5 Future Trends
4.5.1 Advancements in PCR Technologies
4.6 Impact of Drivers and Restraints:
5. PCR Technologies Market - Europe Market Analysis
5.1 PCR Technologies Market Revenue (US$ Million), 2020 - 2030
6. Europe PCR Technologies Market Analysis - By Technology
6.1 Overview
6.2 Real Time PCR
6.2.1 Overview
6.2.2 Real Time PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.3 Conventional PCR
6.3.1 Overview
6.3.2 Conventional PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.4 Reverse Transcription PCR
6.4.1 Overview
6.4.2 Reverse Transcription PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.5 Digital PCR
6.5.1 Overview
6.5.2 Digital PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.6 Multiplex RT PCR
6.6.1 Overview
6.6.2 Multiplex RT PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.7 Hot Start PCR
6.7.1 Overview
6.7.2 Hot Start PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.8 Others
6.8.1 Overview
6.8.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
7. Europe PCR Technologies Market Analysis - By Offerings
7.1 Overview
7.2 PCR Technologies Market Revenue Share, by Offerings 2022 & 2030 (%)
7.3 Reagents and Consumables
7.3.1 Overview
7.3.2 Reagents and Consumables Market, Revenue and Forecast to 2030 (US$ Million)
7.3.2.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Reagents and Consumables
7.3.2.1.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Vial Size
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments Market, Revenue and Forecast to 2030 (US$ Million)
7.4.2.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Instruments
7.5 Software and Services
7.5.1 Overview
7.5.2 Software and Services Market, Revenue and Forecast to 2030 (US$ Million)
8. Europe PCR Technologies Market Analysis - By Application
8.1 Overview
8.2 PCR Technologies Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Gene Expression Analysis
8.3.1 Overview
8.3.2 Gene Expression Analysis Market, Revenue and Forecast to 2030 (US$ Million)
8.4 Genetic Sequencing
8.4.1 Overview
8.4.2 Genetic Sequencing Market, Revenue and Forecast to 2030 (US$ Million)
8.5 Genotyping
8.5.1 Overview
8.5.2 Genotyping Market, Revenue and Forecast to 2030 (US$ Million)
8.6 Nucleic Acid Synthesis
8.6.1 Overview
8.6.2 Nucleic Acid Synthesis Market, Revenue and Forecast to 2030 (US$ Million)
8.7 Standard Validation
8.7.1 Overview
8.7.2 Standard Validation Market, Revenue and Forecast to 2030 (US$ Million)
8.8 Point of Care Diagnostics
8.8.1 Overview
8.8.2 Point of Care Diagnostics Market, Revenue and Forecast to 2030 (US$ Million)
8.9 Environmental Application
8.9.1 Overview
8.9.2 Environmental Application Market, Revenue and Forecast to 2030 (US$ Million)
8.10 Others
8.10.1 Overview
8.10.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
9. Europe PCR Technologies Market Analysis - By End User
9.1 Overview
9.2 PCR Technologies Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospitals and Diagnostic Centers
9.3.1 Overview
9.3.2 Hospitals and Diagnostic Centers Market, Revenue and Forecast to 2030 (US$ Million)
9.4 Academia and Research Institutes
9.4.1 Overview
9.4.2 Academia and Research Institutes Market, Revenue and Forecast to 2030 (US$ Million)
9.5 Pharmaceutical and Biotechnology Companies
9.5.1 Overview
9.5.2 Pharmaceutical and Biotechnology Companies Market, Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
10. Europe PCR Technologies Market -Country Analysis
10.1 Europe: PCR Technologies Market
10.1.1 Overview
10.1.2 Europe PCR Technologies Market Revenue and Forecast and Analysis - By Country
10.1.2.1 Germany
10.1.2.1.1 Overview
10.1.2.2 Germany PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.2.1 Germany PCR Technologies Market Breakdown by Technology
10.1.2.2.2 Germany PCR Technologies Market Breakdown by Offerings
10.1.2.2.2.1 Germany PCR Technologies Market Breakdown by Instruments
10.1.2.2.2.2 Germany PCR Technologies Market Breakdown by Reagents and Consumables
10.1.2.2.2.2.1 Germany PCR Technologies Market Breakdown by Vial Size
10.1.2.2.3 Germany PCR Technologies Market Breakdown by Application
10.1.2.2.4 Germany PCR Technologies Market Breakdown by End User
10.1.2.3 United Kingdom
10.1.2.3.1 Overview
10.1.2.4 United Kingdom PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.4.1 United Kingdom PCR Technologies Market Breakdown by Technology
10.1.2.4.2 United Kingdom PCR Technologies Market Breakdown by Offerings
10.1.2.4.2.1 United Kingdom PCR Technologies Market Breakdown by Instruments
10.1.2.4.2.2 United Kingdom PCR Technologies Market Breakdown by Reagents and Consumables
10.1.2.4.2.2.1 United Kingdom PCR Technologies Market Breakdown by Vial Size
10.1.2.4.3 United Kingdom PCR Technologies Market Breakdown by Application
10.1.2.4.4 United Kingdom PCR Technologies Market Breakdown by End User
10.1.2.5 France
10.1.2.5.1 Overview
10.1.2.6 France PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.6.1 France PCR Technologies Market Breakdown by Offerings
10.1.2.6.1.1 France PCR Technologies Market Breakdown by Instruments
10.1.2.6.1.2 France PCR Technologies Market Breakdown by Reagents and Consumables
10.1.2.6.1.2.1 France PCR Technologies Market Breakdown by Vial Size
10.1.2.6.2 France PCR Technologies Market Breakdown by Application
10.1.2.6.3 France PCR Technologies Market Breakdown by End User
10.1.2.7 Italy
10.1.2.7.1 Overview
10.1.2.8 Italy PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.8.1 Italy PCR Technologies Market Breakdown by Technology
10.1.2.8.2 Italy PCR Technologies Market Breakdown by Offerings
10.1.2.8.2.1 Italy PCR Technologies Market Breakdown by Instruments
10.1.2.8.2.2 Italy PCR Technologies Market Breakdown by Reagents and Consumables
10.1.2.8.2.2.1 Italy PCR Technologies Market Breakdown by Vial Size
10.1.2.8.3 Italy PCR Technologies Market Breakdown by Application
10.1.2.8.4 Italy PCR Technologies Market Breakdown by End User
10.1.2.9 Spain
10.1.2.9.1 Overview
10.1.2.10 Spain PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.10.1 Spain PCR Technologies Market Breakdown by Technology
10.1.2.10.2 Spain PCR Technologies Market Breakdown by Offerings
10.1.2.10.2.1 Spain PCR Technologies Market Breakdown by Instruments
10.1.2.10.2.2 Spain PCR Technologies Market Breakdown by Reagents and Consumables
10.1.2.10.2.2.1 Spain PCR Technologies Market Breakdown by Vial Size
10.1.2.10.3 Spain PCR Technologies Market Breakdown by Application
10.1.2.10.4 Spain PCR Technologies Market Breakdown by End User
10.1.2.11 Rest of Europe
10.1.2.11.1 Overview
10.1.2.12 Rest of Europe PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.12.1 Rest of Europe PCR Technologies Market Breakdown by Technology
10.1.2.12.2 Rest of Europe PCR Technologies Market Breakdown by Offerings
10.1.2.12.2.1 Rest of Europe PCR Technologies Market Breakdown by Instruments
10.1.2.12.2.2 Rest of Europe PCR Technologies Market Breakdown by Reagents and Consumables
10.1.2.12.2.2.1 Rest of Europe PCR Technologies Market Breakdown by Vial Size
10.1.2.12.3 Rest of Europe PCR Technologies Market Breakdown by Application
10.1.2.12.4 Rest of Europe PCR Technologies Market Breakdown by End User
11. PCR Technologies Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the PCR Technologies Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Thermo Fisher Scientific Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Promega Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 QIAGEN NV
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 bioMerieux SA
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Hoffmann-La Roche Ltd
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Bio-Rad Laboratories Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Becton Dickinson and Co
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Takara Bio Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Standard Biotools Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Agilent Technologies Inc
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Ellume Ltd
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
13. Appendix
13.1 About the Insight Partners
13.2 Glossary of Terms
List of Tables
Table 1. PCR Technologies Market Segmentation
Table 2. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Technology
Table 3. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Offerings
Table 4. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Reagents and Consumables
Table 5. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Vial Size
Table 6. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Instruments
Table 7. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Application
Table 8. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By End User
Table 9. Germany PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
Table 10. Germany PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
Table 11. Germany PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
Table 12. Germany PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
Table 13. Germany PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
Table 14. Germany PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
Table 15. Germany PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
Table 16. United Kingdom PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
Table 17. United Kingdom PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
Table 18. United Kingdom PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
Table 19. United Kingdom PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
Table 20. United Kingdom PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
Table 21. United Kingdom PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
Table 22. United Kingdom PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
Table 23. France PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
Table 24. France PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
Table 25. France PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
Table 26. France PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
Table 27. France PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
Table 28. France PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
Table 29. France PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
Table 30. Italy PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
Table 31. Italy PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
Table 32. Italy PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
Table 33. Italy PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
Table 34. Italy PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
Table 35. Italy PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
Table 36. Italy PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
Table 37. Spain PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
Table 38. Spain PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
Table 39. Spain PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
Table 40. Spain PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
Table 41. Spain PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
Table 42. Spain PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
Table 43. Spain PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
Table 44. Rest of Europe PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
Table 45. Rest of Europe PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
Table 46. Rest of Europe PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
Table 47. Rest of Europe PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
Table 48. Rest of Europe PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
Table 49. Rest of Europe PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
Table 50. Rest of Europe PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
Table 51. Recent Inorganic Growth Strategies in the PCR Technologies Market
Table 52. Recent Organic Growth Strategies in the PCR Technologies Market
Table 53. Glossary of Terms, PCR Technologies Market
List of Figures
Figure 1. PCR Technologies Market Segmentation, By Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. PCR Technologies Market Revenue (US$ Million), 2020 - 2030
Figure 4. PCR Technologies Market Share (%) - By Technology, 2022 and 2030
Figure 5. Real Time PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 6. Conventional PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 7. Reverse Transcription PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 8. Digital PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 9. Multiplex RT PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 10. Hot Start PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 11. Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 12. PCR Technologies Market Share (%) - By Offerings, 2022 and 2030
Figure 13. Reagents and Consumables Market Revenue and Forecasts to 2030 (US$ Million)
Figure 14. Instruments Market Revenue and Forecasts to 2030 (US$ Million)
Figure 15. Software and Services Market Revenue and Forecasts to 2030 (US$ Million)
Figure 16. PCR Technologies Market Share (%) - By Application, 2022 and 2030
Figure 17. Gene Expression Analysis Market Revenue and Forecasts to 2030 (US$ Million)
Figure 18. Genetic Sequencing Market Revenue and Forecasts to 2030 (US$ Million)
Figure 19. Genotyping Market Revenue and Forecasts to 2030 (US$ Million)
Figure 20. Nucleic Acid Synthesis Market Revenue and Forecasts to 2030 (US$ Million)
Figure 21. Standard Validation Market Revenue and Forecasts to 2030 (US$ Million)
Figure 22. Point of Care Diagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 23. Environmental Application Market Revenue and Forecasts to 2030 (US$ Million)
Figure 24. Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 25. PCR Technologies Market Share (%) - By End User, 2022 and 2030
Figure 26. Hospitals and Diagnostic Centers Market Revenue and Forecasts to 2030 (US$ Million)
Figure 27. Academia and Research Institutes Market Revenue and Forecasts to 2030 (US$ Million)
Figure 28. Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2030 (US$ Million)
Figure 29. Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 30. Europe: PCR Technologies Market, by Key Country - Revenue (2022) (US$ Million)
Figure 31. Europe PCR Technologies Market Breakdown by Key Countries, 2022 and 2030 (%)
Figure 32. Germany PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
Figure 33. United Kingdom PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
Figure 34. France PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
Figure 35. Italy PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
Figure 36. Spain PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
Figure 37. Rest of Europe PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
Figure 38. Growth Strategies in the PCR Technologies Market
1. Thermo Fisher Scientific Inc
2. Promega Corp
3. QIAGEN NV
4. bioMerieux SA
5. Hoffmann-La Roche Ltd
6. Bio-Rad Laboratories Inc
7. Becton Dickinson and Co
8. Takara Bio Inc
9. Standard BioTools Inc
10. Agilent Technologies Inc
11. Ellume Ltd
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe PCR technologies market.
- Highlights key business priorities to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in Europe PCR technologies market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.